Vivos Initial Public Offering

Sleep apnea whether mild or moderate, along with snoring and sleep-disordered breathing affects millions of people all over the world. Vivos Therapeutics has possibly solved the pervasive and potentially deadly disease through their patented proprietary treatment protocol that targets the underlying cause of obstructive sleep apnea. The Vivos System includes not only the clinical diagnostic protocol but also a patented medical device. This protocol has been designed by professional healthcare providers which includes doctor and specially trained dentists. This protocol is meant to assist patients with obstructive sleep apnea and the varying conditions that are brought on by underdeveloped upper and lower jaws.

The Vivos System, founded by R. Kirk Huntsman and Dr. Dave Singh could be the first permanent, non-surgical solution for individuals of all ages who are suffering from troubled-breathing during their sleep. They also offer non-invasive, structural craniofacial corrections.

Included in the Vivos System is an advanced diagnostic protocol developed by a leadership team of researched scientists and practitioners whose aim is to identify craniofacial abnormalities that combine with the Vivos Appliance System. Vivos Therapeutics work with these practitioners to transform their practice in order to ensure that their treatment can be available worldwide. The integration system assures patients that the practitioners obtain the appropriate clinical and diagnostic knowledge along with advanced training and operational support so that their patients can receive the highest level of care for the best outcome.

Vivos Therapeutics is currently in the process of an Initial Public Offering (IPO). If interested, you have the opportunity to own a stake in the one company that may have found the best cure for obstructive sleep apnea that also comes with long-term benefits. If you are interested, visit vivoslife.com for more information.